Related Experiment Video
Updated: Feb 28, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Tumor-derived factors affecting immune cells
Vincenzo Russo1, Maria Pia Protti2
1Immuno-Biotherapy of Melanoma and Solid Tumors Unit, Division of Experimental Oncology, San Raffaele Scientific Institute, DIBIT, Via Olgettina 58, 20132, Milan, Italy.
Abstract:
Tumor progression is accompanied by the production of a wide array of immunosuppressive factors by tumor and non-tumor cells forming the tumor microenvironment. These factors belonging to cytokines, growth factors, metabolites, glycan-binding proteins and glycoproteins are responsible for the establishment of immunosuppressive networks leading towards tumor promotion, invasion and metastasis. In pre-clinical tumor models, the inactivation of some of these suppressive networks reprograms the phenotypic and functional features of tumor-infiltrating immune cells, ultimately favoring effective anti-tumor immune responses. We will discuss factors and mechanisms identified in both mouse and human tumors, and the possibility to associate drugs inhibiting these mechanisms with new immunotherapy strategies already entered in the clinical practice.
Insights
Tumor microenvironment factors create immunosuppressive networks that promote cancer progression. Inhibiting these factors can reprogram immune cells for effective anti-tumor responses, enhancing immunotherapy strategies.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Tumor progression involves immunosuppressive factors from tumor and non-tumor cells within the tumor microenvironment.
- These factors, including cytokines, growth factors, and glycoproteins, establish immunosuppressive networks that drive tumor promotion, invasion, and metastasis.
Purpose of the Study:
- To discuss immunosuppressive factors and mechanisms in both mouse and human tumors.
- To explore the potential of combining drugs that inhibit these mechanisms with current immunotherapy strategies.
Main Methods:
- Review of pre-clinical tumor models demonstrating the effects of inactivating suppressive networks.
- Analysis of factors and mechanisms identified in both murine and human tumor studies.
Main Results:
- Inactivation of specific immunosuppressive networks reprograms tumor-infiltrating immune cells.
- This reprogramming enhances anti-tumor immune responses, favoring tumor suppression.
Conclusions:
- Targeting immunosuppressive networks within the tumor microenvironment is a promising strategy.
- Combining inhibitors of these networks with immunotherapy holds potential for improved cancer treatment outcomes.
Related Concept Videos
Tumor Immunotherapy
The Tumor Microenvironment
Regulation of Hematopoietic Stem Cells
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mitogens and the Cell Cycle
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

